U
Nirvana Life Sciences Inc. NIRVF
$0.0083 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

10/31/2024 07/31/2024 04/30/2024 01/31/2024 10/31/2023
Net Income -44.70K -40.90K -256.30K 4.00K -124.00K
Total Depreciation and Amortization -- -- 4.50K 9.00K --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 20.30K -100.00 135.70K -109.00K 33.80K
Change in Net Operating Assets 3.40K 40.20K 111.80K 89.70K 38.30K
Cash from Operations -21.00K -800.00 -4.30K -6.30K -51.90K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 37.60K 5.30K 4.60K 2.00K 13.60K
Total Debt Repaid -- -- 50.00K 0.00 0.00
Issuance of Common Stock -- -- -- 0.00 25.00K
Repurchase of Common Stock -- -- -59.10K -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 9.10K 0.00 0.00
Cash from Financing 27.60K 3.80K 3.40K 1.50K 28.40K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -9.10K -2.20K -- -- --
Net Change in Cash -2.50K 800.00 -900.00 -4.80K -23.40K
Weiss Ratings